Immune responses to methamphetamine by active immunization with peptide-based, molecular adjuvant-containing vaccines. (Q46018289)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19428909%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

title

Immune responses to methamphetamine by active immunization with peptide-based, molecular adjuvant-containing vaccines (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19428909%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

0 references

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19428909%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Jennifer E. Murray

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19428909%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Geoffrey M. Thiele

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19428909%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Carmela M Reichel

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19428909%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

author name string

Michael J Duryee

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19428909%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Yuxiang Dong

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19428909%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Sam D Sanderson

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19428909%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

language of work or name

English

0 references

publication date

10 March 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19428909%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19428909%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19428909%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

issue

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19428909%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

page(s)

2981-2988

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19428909%20AND%20SRC:MED&resulttype=core&format=json

Ice: a new dosage form of an old drug

27 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.105

Multiple modes of hepatitis A virus transmission among methamphetamine users.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.105

Management of methamphetamine abuse and dependence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.105

Psychophysiological aspects of amphetamine-methamphetamine abuse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.105

Amphetamine: effects on catecholamine systems and behavior

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.105

Approaches to the development of medications for the treatment of methamphetamine dependence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.105

Efficacy of a therapeutic cocaine vaccine in rodent models.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.105

Vaccines against drugs of abuse: a viable treatment option?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.105

Effects of passive immunization against morphine on heroin self-administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.105

Immunotherapy for the treatment of drug abuse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.105

A nicotine conjugate vaccine reduces nicotine distribution to brain and attenuates its behavioral and cardiovascular effects in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.105

Immunization to nicotine with a peptide-based vaccine composed of a conformationally biased agonist of C5a as a molecular adjuvant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.105

Generation of anti-(+)methamphetamine antibodies is not impeded by (+)methamphetamine administration during active immunization of rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.105

Biologically active conformer of the effector region of human C5a and modulatory effects of N-terminal receptor binding determinants on activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.105

Response-selective C5a agonists: differential effects on neutropenia and hypotension in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.105

Development of response-selective agonists of human C5a anaphylatoxin: conformational, biological, and therapeutic considerations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.105

Induction of an antigen-specific CTL response by a conformationally biased agonist of human C5a anaphylatoxin as a molecular adjuvant.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.105

A conformationally-biased, response-selective agonist of C5a acts as a molecular adjuvant by modulating antigen processing and presentation activities of human dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.105

A peptide carrier with a built-in vaccine adjuvant: construction of immunogenic conjugates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.105

Bupropion differentially impacts acquisition of methamphetamine self-administration and sucrose-maintained behavior.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.105

Intravenous nicotine conditions a place preference in rats using an unbiased design

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.105

Effects of dopamine indirect agonists and selective D1-like and D2-like agonists and antagonists on cocaine self-administration and food maintained responding in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.105

Nicotine self-administration in rats on a progressive ratio schedule of reinforcement.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.105

Vaccination against nicotine during continued nicotine administration in rats: immunogenicity of the vaccine and effects on nicotine distribution to brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.105

Evaluation of anti-cocaine antibodies and a cocaine vaccine in a rat self-administration model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.105

Human therapeutic cocaine vaccine: safety and immunogenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.105

Development of murine monoclonal antibodies to methamphetamine and methamphetamine analogues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.105

Use of anti-(+)-methamphetamine monoclonal antibody to significantly alter (+)-methamphetamine and (+)-amphetamine disposition in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.105

Monoclonal IgG affinity and treatment time alters antagonism of (+)-methamphetamine effects in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.105

Effects of murine-derived anti-methamphetamine monoclonal antibodies on (+)-methamphetamine self-administration in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.105

Parameters of self-administration of cocaine in rats under a progressive-ratio schedule.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.105

Effects of dopamine agonists and antagonists on cocaine-induced operant responding for a cocaine-associated stimulus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.105

Vaccines to combat smoking

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.105

Vaccines against nicotine: how effective are they likely to be in preventing smoking?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.105